ASP Isotopes Inc. (ASPI): M&A transaction — ASP Isotopes closes acquisition of Renergen; issues 14.27M shares; new execs appointed

ASP Isotopes Inc.

Acquired all Renergen shares via scheme of arrangement; exchange ratio 0.09196 ASPI share per Renergen share.
Issued 14,270,000 shares; Renergen becomes wholly owned subsidiary; delisted from JSE, ASX, A2X.
Combined company targets helium and isotopes; Renergen's Virginia Gas project has $40M US DFC funding plus expected $500M DFC and $250M Standard Bank debt facilities.
Renergen CEO Stefano Marani appointed President, Electronics and Space; COO Nick Mitchell appointed Co-COO.
Inducement grants of 700,000 restricted shares each to Marani and Mitchell, vesting over four years.

item 2.01 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

ASP Isotopes Inc. completed an acquisition involving Renergen Limited (closed 2026-01-06).

Action: acquisition
Counterparty: Renergen Limited
Closing: 2026-01-06

Exact text from the filing

On the Closing Date, ASP Isotopes acquired all of the issued Renergen Ordinary Shares from Renergen shareholders in exchange for shares of Company Common Stock at an exchange ratio of 0.09196 shares of Company Common Stock for each Renergen Ordinary Share (the “Consideration Shares”) through the implementation of the Scheme, resulting in the issuance of an aggregate of 14,270,000 Consideration Shares.

View on SEC.gov

Browse all m&a transactions →

ASP Isotopes Inc. filing history →

Source: SEC EDGAR

accession 0001477932-26-000055

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.